Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Pontremoli

Showing results (51-60 of 211) with videos related to

Pageof 22
Sort By:
Journal of Nephrology|May 18, 2022
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?Luca De Nicola, Mario Cozzolino, Simonetta Genovesi, et al.
Journal of Nephrology|July 19, 2020
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitationsGiovanna Leoncini, Francesca Viazzi, Salvatore De Cosmo, et al.
Panminerva Medica|March 26, 2021
The URRAH studyRita Del Pinto, Francesca Viazzi, Roberto Pontremoli, et al.
Journal of Clinical Medicine|March 6, 2021
Treating Hyperuricemia: The Last Word Hasn't Been Said YetElisa Russo, Daniela Verzola, Giovanna Leoncini, et al.
Medicina (Kaunas, Lithuania)|June 5, 2019
GLP-1 Receptor Agonists and Kidney ProtectionEulalia Valentina Greco, Giuseppina Russo, Annalisa Giandalia, et al.
Internal and Emergency Medicine|September 29, 2023
Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitorsLuca De Nicola, Pietro Manuel Ferraro, Andrea Montagnani, et al.
Journal of Nephrology|April 25, 2020
Atherogenic dyslipidemia and diabetic nephropathyGiuseppina Russo, Pamela Piscitelli, Annalisa Giandalia, et al.
Plos One|December 17, 2014
Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4Daniela Verzola, Elena Ratto, Barbara Villaggio, et al.
Diabetes Research and Clinical Practice|November 3, 2019
Impact of CVOTs in primary and secondary prevention of kidney diseaseSalvatore De Cosmo, Francesca Viazzi, Pamela Piscitelli, et al.
Internal and Emergency Medicine|December 23, 2019
Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefitsGiuliano Tocci, Barbara Citoni, Vivianne Presta, et al.
Pageof 22

Showing results (51-60 of 211) with videos related to

Sort By:
Pageof 22
Journal of Nephrology|May 18, 2022
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?Luca De Nicola, Mario Cozzolino, Simonetta Genovesi, et al.
Journal of Nephrology|July 19, 2020
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitationsGiovanna Leoncini, Francesca Viazzi, Salvatore De Cosmo, et al.
Panminerva Medica|March 26, 2021
The URRAH studyRita Del Pinto, Francesca Viazzi, Roberto Pontremoli, et al.
Journal of Clinical Medicine|March 6, 2021
Treating Hyperuricemia: The Last Word Hasn't Been Said YetElisa Russo, Daniela Verzola, Giovanna Leoncini, et al.
Medicina (Kaunas, Lithuania)|June 5, 2019
GLP-1 Receptor Agonists and Kidney ProtectionEulalia Valentina Greco, Giuseppina Russo, Annalisa Giandalia, et al.
Internal and Emergency Medicine|September 29, 2023
Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitorsLuca De Nicola, Pietro Manuel Ferraro, Andrea Montagnani, et al.
Journal of Nephrology|April 25, 2020
Atherogenic dyslipidemia and diabetic nephropathyGiuseppina Russo, Pamela Piscitelli, Annalisa Giandalia, et al.
Plos One|December 17, 2014
Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4Daniela Verzola, Elena Ratto, Barbara Villaggio, et al.
Diabetes Research and Clinical Practice|November 3, 2019
Impact of CVOTs in primary and secondary prevention of kidney diseaseSalvatore De Cosmo, Francesca Viazzi, Pamela Piscitelli, et al.
Internal and Emergency Medicine|December 23, 2019
Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefitsGiuliano Tocci, Barbara Citoni, Vivianne Presta, et al.
Pageof 22